Biotech update from Bret Jensen.
http://investorinthefamily.com/)
Outperforming market in 2017 after 18 month bear
Big uptick in M&A in Jan
3 big deals
Feb and Mar have been fairly flat
Lots of resistance technically
Need an uptick in MA or earnings to break through
Expect the uptick to happen in MA
Watch Trump’s actions and not words
Has appointed 2 free market minded people (FDA,
Proposed to double fees for drug approval
Watching repeal and replace of ACA
Needs to happen before tax and regulatory reform
Expect the repeal to happen by April or May
Ocular Therapeutix (OCUL)
Trigger event in July, new product for cataract surgery
Insider buying
Omerisk (OMER)
OMS721
Priced at just over $10 w PTs in the $30
Next trigger event in few years
